Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol sedation for recovery quality after outpatient colonoscopy
ChiCTR2200056092Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jan 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and fentanyl in None (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of overall PostopQRS recovery. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
remimazolampropofolfentanyl
Beyond the preview
Go deeper on ChiCTR2200056092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056092.